Eventide Asset Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-664,829
| Closed | -$3.01M | – | 141 |
|
|
2023
Q1 | $3.01M | Sell |
664,829
-237,171
| -26% | -$1.07M | 0.06% | 132 |
|
|
2022
Q4 | $10.2M | Hold |
902,000
| – | – | 0.2% | 105 |
|
|
2022
Q3 | $8.63M | Buy |
+902,000
| New | +$8.63M | 0.17% | 108 |
|
|
2021
Q3 | – | Sell |
-439,950
| Closed | -$24.1M | – | 152 |
|
|
2021
Q2 | $24.1M | Buy |
439,950
+349,950
| +389% | +$19.1M | 0.32% | 81 |
|
|
2021
Q1 | $6.64M | Buy |
+90,000
| New | +$6.64M | 0.1% | 123 |
|